Cargando…
Schedule‐dependent and ‐independent Antitumor Activity of Paclitaxel‐based Combination Chemotherapy against M‐109 Murine Lung Carcinoma in vivo
The established antitumor efficacy of paclitaxel against a variety of human tumors has led to pre‐clinical and clinical studies to develop the paclitaxel‐based combination regimens. We examined in vivo the antitumor activity and toxicity of the combination of paclitaxel and each of 8 antitumor agent...
Autores principales: | Fujimoto, Shuichi, Chikazawa, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921735/ https://www.ncbi.nlm.nih.gov/pubmed/10081496 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00532.x |
Ejemplares similares
-
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Anti‐tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
por: Yamori, Takao, et al.
Publicado: (1997) -
Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
por: Zuco, Valentina, et al.
Publicado: (2011) -
nab-Paclitaxel dose and schedule in breast cancer
por: Martín, Miguel
Publicado: (2015) -
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
por: Xu, Mei-Qi, et al.
Publicado: (2021)